Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q35053972)
Watch
English
Bone markers in the management of patients with skeletal metastases
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
12548589
retrieved
6 August 2017
review article
1 reference
stated in
Europe PubMed Central
title
Bone markers in the management of patients with skeletal metastases
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
12548589
retrieved
6 August 2017
author name string
Laurence M Demers
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
12548589
retrieved
6 August 2017
language of work or name
English
0 references
publication date
1 February 2003
1 reference
stated in
Europe PubMed Central
PubMed ID
12548589
retrieved
6 August 2017
number of pages
6
1 reference
based on heuristic
inferred from page(s)
published in
Cancer
1 reference
stated in
Europe PubMed Central
PubMed ID
12548589
retrieved
6 August 2017
volume
97
1 reference
stated in
Europe PubMed Central
PubMed ID
12548589
retrieved
6 August 2017
page(s)
874-879
1 reference
stated in
Europe PubMed Central
PubMed ID
12548589
retrieved
6 August 2017
issue
3 Suppl
1 reference
stated in
Europe PubMed Central
PubMed ID
12548589
retrieved
6 August 2017
cites work
The clinical course of bone metastases from breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Breast cancer cells interact with osteoblasts to support osteoclast formation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Osteolysis and cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: potential implications for the pathogenesis and treatment of malignant bone diseases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Urinary carboxyterminal telopeptide of collagen I as a potential marker of bone metastases chemotherapy monitoring in breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Serum concentration of type I collagen metabolites as a quantitative marker of bone metastases in patients with prostate carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Urinary pyridinoline and deoxypyridinoline as potential markers of bone metastasis in patients with prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Markers of type I collagen degradation and synthesis in the monitoring of treatment response in bone metastases from breast carcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Type I collagen degradation product (ICTP) gives information about the nature of bone metastases and has prognostic value in prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Biochemical markers and skeletal metastases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bone resorption by osteoclasts
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bisphosphonates regulate cell growth and gene expression in the UMR 106-01 clonal rat osteosarcoma cell line
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gene expression of osteoprotegerin ligand, osteoprotegerin, and receptor activator of NF-kappaB in giant cell tumor of bone: possible involvement in tumor cell-induced osteoclast-like cell formation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Osteoprotegerin and rank ligand expression in prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased serum osteoprotegerin in disorders characterized by persistent immune activation or glucocorticoid excess--possible role in bone homeostasis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The ligand for osteoprotegerin (OPGL) directly activates mature osteoclasts.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.11127
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/CNCR.11127
1 reference
stated in
Europe PubMed Central
PubMed ID
12548589
retrieved
6 August 2017
PubMed ID
12548589
1 reference
stated in
Europe PubMed Central
PubMed ID
12548589
retrieved
6 August 2017
ResearchGate publication ID
10932008
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
